203 related articles for article (PubMed ID: 27213922)
1. Light-Responsive Biodegradable Nanomedicine Overcomes Multidrug Resistance via NO-Enhanced Chemosensitization.
Fan J; He Q; Liu Y; Zhang F; Yang X; Wang Z; Lu N; Fan W; Lin L; Niu G; He N; Song J; Chen X
ACS Appl Mater Interfaces; 2016 Jun; 8(22):13804-11. PubMed ID: 27213922
[TBL] [Abstract][Full Text] [Related]
2. ROS and GSH-responsive S-nitrosoglutathione functionalized polymeric nanoparticles to overcome multidrug resistance in cancer.
Wu W; Chen M; Luo T; Fan Y; Zhang J; Zhang Y; Zhang Q; Sapin-Minet A; Gaucher C; Xia X
Acta Biomater; 2020 Feb; 103():259-271. PubMed ID: 31846803
[TBL] [Abstract][Full Text] [Related]
3. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
4. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
5. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
6. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
7. pH and near-infrared light dual-stimuli responsive drug delivery using DNA-conjugated gold nanorods for effective treatment of multidrug resistant cancer cells.
Zhang W; Wang F; Wang Y; Wang J; Yu Y; Guo S; Chen R; Zhou D
J Control Release; 2016 Jun; 232():9-19. PubMed ID: 27072026
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembled Monomethoxy (Polyethylene Glycol)-b-P(D,L-Lactic-co-Glycolic Acid)-b-P(L-Glutamic Acid) Hybrid-Core Nanoparticles for Intracellular pH-Triggered Release of Doxorubicin.
Xu H; Cai C; Gou J; Sui B; Jin J; Xu H; Zhang Y; Wang L; Zhai Y; Tang X
J Biomed Nanotechnol; 2015 Aug; 11(8):1354-69. PubMed ID: 26295138
[TBL] [Abstract][Full Text] [Related]
9. Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.
Qi Y; Qin X; Yang C; Wu T; Qiao Q; Song Q; Zhang Z
Mol Pharm; 2018 Mar; 15(3):1005-1016. PubMed ID: 29397749
[TBL] [Abstract][Full Text] [Related]
10. A nanoparticulate pre-chemosensitizer for efficacious chemotherapy of multidrug resistant breast cancer.
Guo S; Lv L; Shen Y; Hu Z; He Q; Chen X
Sci Rep; 2016 Feb; 6():21459. PubMed ID: 26875787
[TBL] [Abstract][Full Text] [Related]
11. Zinc Oxide Nanoparticles as Adjuvant To Facilitate Doxorubicin Intracellular Accumulation and Visualize pH-Responsive Release for Overcoming Drug Resistance.
Liu J; Ma X; Jin S; Xue X; Zhang C; Wei T; Guo W; Liang XJ
Mol Pharm; 2016 May; 13(5):1723-30. PubMed ID: 27070828
[TBL] [Abstract][Full Text] [Related]
12. Light-Switchable Yolk-Mesoporous Shell UCNPs@MgSiO
Li S; Song X; Zhu W; Chen Y; Zhu R; Wang L; Chen X; Song J; Yang H
ACS Appl Mater Interfaces; 2020 Jul; 12(27):30066-30076. PubMed ID: 32393026
[TBL] [Abstract][Full Text] [Related]
13. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
14. A novel self-assembled sandwich nanomedicine for NIR-responsive release of NO.
Fan J; He N; He Q; Liu Y; Ma Y; Fu X; Liu Y; Huang P; Chen X
Nanoscale; 2015 Dec; 7(47):20055-62. PubMed ID: 26568270
[TBL] [Abstract][Full Text] [Related]
15. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N
Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072
[TBL] [Abstract][Full Text] [Related]
16. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
17. Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo.
Mao X; Si J; Huang Q; Sun X; Zhang Q; Shen Y; Tang J; Liu X; Sui M
Adv Healthc Mater; 2016 Oct; 5(19):2517-2527. PubMed ID: 27529558
[TBL] [Abstract][Full Text] [Related]
18. Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model.
Shuhendler AJ; Prasad P; Zhang RX; Amini MA; Sun M; Liu PP; Bristow RG; Rauth AM; Wu XY
Mol Pharm; 2014 Aug; 11(8):2659-74. PubMed ID: 24830351
[TBL] [Abstract][Full Text] [Related]
19. Glutathione detonated and pH responsive nano-clusters of Au nanorods with a high dose of DOX for treatment of multidrug resistant cancer.
Wang Y; Wang F; Liu Y; Xu S; Shen Y; Feng N; Guo S
Acta Biomater; 2018 Jul; 75():334-345. PubMed ID: 29885528
[TBL] [Abstract][Full Text] [Related]
20. Real-time visualization of pH-responsive PLGA hollow particles containing a gas-generating agent targeted for acidic organelles for overcoming multi-drug resistance.
Ke CJ; Chiang WL; Liao ZX; Chen HL; Lai PS; Sun JS; Sung HW
Biomaterials; 2013 Jan; 34(1):1-10. PubMed ID: 23044041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
